Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Want To Invest Like The World's Largest Hedge Fund? 2 High Yielders That Are Recession Proof

Published 21/09/2022, 15:20
Updated 21/09/2022, 16:11
© Reuters.  Want To Invest Like The World's Largest Hedge Fund? 2 High Yielders That Are Recession Proof

With macroeconomic conditions remaining uncertain, billionaire Ray Dalio called for a 20% downside in equities if the Federal Reserve raises interest rates to 4.5%.

His hedge fund, Bridgewater Associates, holds some 985 positions. The dividend stocks mentioned below are Dalio’s top two positions.

Considering Bridgewater is the world's largest hedge fund with $154 billion in assets under management, and Dalio ties with Rocket Companies (NYSE: RKT) co-founder Daniel Gilbert among the richest billionaires with a net worth of $22 billion, investors would be wise to follow his lead:

  • Procter & Gamble Co. (NYSE: PG) is offering a dividend yield of 2.64% or $3.65 per share annually, using quarterly payments, with a dividend king track record of increasing its dividends for 66 years. The company's lineup of brands (i.e., Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers) includes more than 20 that generate north of $1 billion each in annual global sales. Procter & Gamble returned nearly $19 billion of value to shareholders in fiscal 2022 via $8.8 billion in dividend payments and $10 billion of share repurchases.
  • Johnson & Johnson (NYSE: JNJ (NYSE:JNJ)) is offering a dividend yield of 2.74% or $4.52 per share annually, making quarterly payments, with a stellar track record of increasing its dividends for 60 years. The world's largest and most diverse healthcare firm operates in three divisions (pharmaceutical, medical devices and diagnostics, and consumer). On Sept. 14, Johnson & Johnson announced that the board of directors has authorized the repurchase of up to $5 billion of the company's common stock.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.